On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

ECDC report on its country visit to Finland in October 2012
It provides an overview of Finland’s national strategies and programmes for HIV and sexually transmitted diseases. A few highlights: • Prevention and care need to be adapted to a changed HIV epidemiology. Most infections seem to now occur among heterosexuals, either migrants coming from high-prevalence countries or Finnish nationals with travel-associated HIV infections. • Late diagnosis is frequent in all sub-populations. • It should be considered whether harm reduction would be expanded by providing clean injection rooms in low-threshold health service centres for IDUs. • It is suggested that it should be considered whether substitution treatment could be started in prison
Drug Policy Reform In Action: A 21st Century Approach
White House Office of National Drug Control Policy Director, Gil Kerlikowske touts the U.S.’s latest drug control strategy as a “21st Century Approach to drug policy reform” in the Huff Post blog. Read the newly released U.S. Drug Strategy (at http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf) and tell us what you think on our forums. And see 100 American celebrities who unite to call for an end to the war on drugs: http://globalgrind.com/endthewarondrugs
Intercambios April Newsletter
The Intercambios April Newsletter is available in Spanish and English. This issue highlights, the Commission on Narcotic Drugs, Drugs, HIV and civil society in Vienna, the 'new voice of drug policy' and much more.
Blueprint for a Public Health and Safety Approach to Drug Policy
“For decades, New York State has expended significant resources on drug use prevention, interdiction, and incarceration with relatively modest effect in stopping drug use or reducing the morbidity and mortality associated with it." The New York Academy of Medicine and Drug Policy Alliance in their new report, call for a paradigm shift to "a coordinated, evidence-based, and cost-efficient approach that reduces the harms of both drug use and our drug policies, while improving the health and safety of communities across the state.”
Breaking worse: The emergence of krokodil and excessive injuries among people who inject drugs in Eurasia
Jean-Paul C. Grunda et al. conclude from the study that "a comprehensive response to the emergence of krokodil and associated harms should focus both on the substance itself and its rudimentary production methods, as well as on its micro and macro risk environments."
Unsafe injection practices in Hodeidah governorate, Yemen
This study by Mohammed Abdu Abdu Akbar et al. "revealed several unsafe practices, particularly the recapping of needles after use, which occurred in 61.1% and 36.8% of the observations in the hospitals and the health centers, respectively."
In a class of their own
Editorial about Dr Mary Heapburn (IDHDP member) in the Herald Scotland.
Promoting health in prison
This editorial in the British Medical Journal (BMJ) investigates "how prisons contain some of the most disadvantaged people but they can also provide opportunities to improve their health and early intervention could help them to keep them out of prison. 62% of prisoners in UK are on directly observed therapy (FOR TB) were homeless on release, with less than half completing a full course of treatment."
International seminar in Mexico about new focuses in drug policy
International drug policy experts gathered in the Mexican Parliament (Cámara de Diputados) to reopen the debate during the international seminar: Regulation and Legislation: New focuses in Drug Policy. Read the blog from Cavazos He Arozqueta.
Access to Analgesics and to Other Controlled Medications
"WHO have developed the Access to Controlled Medications Programme (ACMP) in consultation with the International Narcotics Control Board (INCB). The Programme aims to improve legitimate medical access to all medications controlled under the drug conventions."
Share this on: